. "Appendix 20: Respiratory Syncytial Virus." Vaccines for the 21st Century: A Tool for Decisionmaking. Washington, DC: The National Academies Press, 2000.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Vaccines for the 21st Century: A Tool for Decisionmaking
Hall CB, McCarthy CA. Respiratory Syncytial Virus. In: Principles and Practice of Infectious Diseases. GL Mandell, JE Bennett, Dolin R eds. New York, NY: Churchill Livingstone, 1995, pp. 1501–1519.
Meissner HC, Groothuis JR. Immunoprophylaxis and the Control of RSV Disease. Pediatrics 1997; 100:260–263.
Paradise JL, Rockette HE, Colborn DK, et al. Otitis Media in 2253 Pittsburgh-Area Infants: Prevalence and Risk Factors During the First Two Years of Life. Pediatrics 1997; 99:318–333.
Prober CG, Wang EEL. Reducing the Morbidity of Lower Respiratory Tract Infections Caused by Respiratory Syncytial Virus: Still No Answer. Pediatrics 1997; 99:472–475.
Rodriguez WJ, Gruber WC, Welliver RC, et al. Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections. Pediatrics 1997; 99:454–461.
Ventura SJ, Martin JA, Mathews TJ, et al. Advance Report of Final Natality Statistics, 1994. Monthly Vital Statistics Report 1996; 44.
